Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €80.00 Price Target by Jefferies Financial Group Analysts

Jefferies Financial Group set a €80.00 ($93.02) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Tuesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

FME has been the topic of a number of other reports. Deutsche Bank set a €100.00 ($116.28) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, October 30th. UBS Group set a €90.00 ($104.65) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, October 29th. Berenberg Bank set a €89.95 ($104.59) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, October 29th. Barclays set a €78.00 ($90.70) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Friday, October 18th. Finally, Sanford C. Bernstein set a €73.00 ($84.88) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of €79.11 ($91.99).

FME opened at €72.02 ($83.74) on Tuesday. The stock has a market cap of $21.63 billion and a PE ratio of 17.14. The company has a current ratio of 0.98, a quick ratio of 0.62 and a debt-to-equity ratio of 101.27. Fresenius Medical Care AG & Co. KGaA has a 1 year low of €57.24 ($66.56) and a 1 year high of €76.68 ($89.16). The stock’s 50 day simple moving average is €66.28 and its 200-day simple moving average is €64.34.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: What is quantitative easing?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.